United States Predictive Diagnostics Market Set to Surge to $139B by 2031 - Driving Personalized & Preventive Healthcare | Abbott Laboratories, Certis Oncology Solutions, Inc., Proteomics International Laboratories Ltd

The Global Predictive Diagnostics Market reached US$ 48.67 billion in 2023 and is expected to reach US$ 139.18 billion by 2031, growing at a CAGR of 14.70% during the forecast period 2024-2031.

Predictive diagnostics refers to advanced diagnostic tools and technologies that assess the likelihood of disease development or progression, enabling proactive healthcare management. These solutions leverage genomics, proteomics, biomarkers, AI, and machine learning to provide early warnings and personalized risk assessments. The market is expanding due to rising prevalence of chronic and genetic diseases, growing adoption of personalized medicine, and technological advancements in diagnostic analytics. Key applications include oncology, cardiovascular diseases, metabolic disorders, and neurodegenerative conditions.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Predictive Diagnostics Market Landscape:- https://datamintelligence.com/download-sample/predictive-diagnostics-market?rk

☛ Predictive Diagnostics Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In August 2025, Invitae launched its AI-driven predictive diagnostics platform to identify genetic risk factors for hereditary diseases, enabling early intervention and personalized care.

✅ In July 2025, Tempus expanded its predictive diagnostic tools for oncology, integrating clinical and genomic data to forecast patient responses to therapies.

✅ In June 2025, Exact Sciences partnered with U.S. hospitals to implement predictive screening tests for early detection of colorectal and other cancers.

Europe: Recent Industry Developments

✅ In July 2025, SOPHiA Genetics deployed predictive diagnostic solutions across EU hospitals, combining AI analytics with genomic and clinical data for precision healthcare.

✅ In June 2025, Qiagen launched early risk assessment diagnostics for cardiovascular and metabolic diseases in European markets, supporting preventive healthcare strategies.

✅ In May 2025, Eurofins Scientific partnered with European clinics to provide predictive testing platforms for oncology and rare diseases, enhancing early detection and treatment planning.

Japan: Recent Industry Developments

✅ In July 2025, Sysmex Corporation expanded its predictive diagnostics portfolio for oncology and hematologic disorders in Japanese hospitals and research centers.

✅ In June 2025, Fujifilm Healthcare launched AI-enabled predictive diagnostic tools for early disease detection, supporting precision medicine initiatives in Japan.

✅ In May 2025, Takeda Pharmaceutical collaborated with healthcare institutions to implement genomic and predictive testing platforms, enhancing proactive patient care strategies.

☛ Predictive Diagnostics Market Trends:

Technological Advancements: Integration of AI-driven analytics, next-generation sequencing (NGS), and multi-omics data is improving prediction accuracy, enabling early interventions and personalized treatment strategies.

Rising Demand for Preventive Healthcare: Increasing healthcare awareness and focus on early detection and disease prevention are driving adoption in hospitals, clinics, and diagnostic laboratories.

Market Segmentation: Genomic and biomarker-based predictive diagnostics dominate due to their precision, while AI-powered software solutions are growing rapidly for real-time risk assessment and patient management.

Regional Insights: North America leads the market due to advanced healthcare infrastructure, high R&D investment, and regulatory support. Asia-Pacific is emerging as a key growth region with expanding healthcare access, increasing chronic disease prevalence, and government initiatives supporting preventive care.

Challenges: High costs of testing, regulatory complexities, and data privacy concerns may hinder widespread adoption in certain regions.

Strategic Initiatives: Companies are focusing on R&D collaborations, AI-based platform development, and partnerships with healthcare providers to improve predictive accuracy and market penetration.

☛ Predictive Diagnostics Market Competitve Landscape:

Abbott Laboratories, Certis Oncology Solutions, Inc., Proteomics International Laboratories Ltd, QIAGEN N.V., Prometheus Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Myriad Genetics, Exact Sciences Corporation, and Reliance Life Sciences.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/predictive-diagnostics-market

☛ Segment Covered in the Predictive Diagnostics Market:

By Type: Presymptomatic | Predispositional

By Application: Cardiovascular Diseases | Neurological Diseases | Genetic Diseases | Oncology | Others

By End-User: Diagnostic Centers | Genetic Laboratories and Clinics | Research and Academic Institutes

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Predictive Diagnostics Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=predictive-diagnostics-market

☛ Regional Analysis for Predictive Diagnostics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

☛ Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Predictive Diagnostics Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Predictive Diagnostics Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Predictive Diagnostics Market?
➠ What sales, marketing, and distribution channels are used globally?

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.